Crunchbase News

FEBRUARY 4, 2025

Venture money wasnt concentrated in just one sector, as VCs invested in everything from artificial intelligence to biotech to energy. tied) Retro Biosciences , $1B, biotech: AI can do a lot startup Retro Biosciences thinks it can even help us live longer. billion valuation. In November 2021, Helion closed a $500 million Series E.

Biotech 123

Biotech Artificial Intelligence Artificial Inteligence Technical Review 123

TechCrunch

MARCH 17, 2023

Full TechCrunch+ articles are only available to members Use discount code TCPLUSROUNDUP to save 20% off a one- or two-year subscription Before Silicon Valley Bank crashed, I asked seven VCs about the startups they’re interested in backing right now, how they prefer to be approached and whether they could share any tips for first-time founders. “The

Budget 230

Budget Biotech Artificial Inteligence Banking 230

TechCrunch

DECEMBER 9, 2020

This allows product developers to review and discuss 3D models in more than 30 file formats in real time. The idea is to democratize access to normally expensive product lifecycle management (PLM) software.

Hardware 252

Hardware 3D Quality Assurance Biotech 252

CIO

JULY 30, 2024

Some industries such as biotech are finding ways to use gen AI, but many enterprises experimenting with the technology have found a limited number of use cases so far, says Kjell Carlsson, head of AI strategy at Domino Data Lab, provider of an enterprise AI platform. “The

Generative AI 216

Generative AI Artificial Inteligence Software Review Fractional CTO 216

Crunchbase News

MARCH 11, 2025

That increase was due in large part to U.S. AI led The 2024 surge in new unicorns was led by the AI sector, which included companies focused on foundation models, AI infrastructure and coding. Healthcare and biotech was the third-highest sector for new unicorns with nine companies. US gained Of the new 2024 unicorns, 65 are U.S.-based

Fintech 119

Fintech Technical Review Biotech Healthcare 119

TechCrunch

MAY 17, 2021

Every branch of science is increasingly reliant on big data sets and analysis, which means a growing confusion of formats and platforms — more than inconvenient, this can hinder the process of peer review and replication of research. That, at least, is the pitch Code Ocean offers for its platform and “Compute Capsules.”

Software Review 179

Software Review Research Data Analysis 179

Crunchbase News

MARCH 21, 2025

Latigo Biotherapeutics , $150M, biotech: Many patients shy away from taking opioids while many doctors are reluctant to prescribe the painkillers. Curevo , $110M, biotech: Seattle-based Curevo, a clinical-stage biotechnology company developing vaccinations for infectious disease, closed a $110 million Series B led by new investor Medicxi.

Biotech 66

Biotech Software Review Technical Review Analytics 66

CIO

APRIL 17, 2024

Normally, a CCO develops ideas about what the market needs and communicates them to a design team, which produces sketches to then be reviewed by the CCO. Helping software developers write and test code Similarly in tech, companies are currently open about some of their use cases, but protective of others.

Software Review 194

Software Review Enterprise Generative AI Artificial Inteligence 194

TechCrunch

DECEMBER 28, 2021

Deep tech, medtech/biotech, climate tech, and crypto and blockchain are all areas that investors say they’re either actively investing in or watching for signs of scale. Now, certain industries are emerging as potential areas where New Zealand can win in the tech space. New Zealanders make really good founders.

Technical Review 236

Technical Review Blockchain Biotech Software Review 236

TechCrunch

JUNE 9, 2021

According to research, 85% of African SMBs have zero access to financing, and e ach day, African SMBs have billions locked up in receivables due to long payment cycles. ” All the companies from Y Combinator’s W20 Demo Day, Part IV: Healthcare, Biotech, Fintech and Nonprofits.

Banking 348

Banking Technical Review Fintech Media 348

TechCrunch

OCTOBER 6, 2022

France could become a leading market when it comes to sustainability-focused and impact startups due to local and European regulation, innovation and talent looking for opportunities in this ecosystem. But impact companies could still benefit from new processes, better network effects and more ambition in general.

Sustainability 188

Sustainability Programming Technical Review Biotech 188

Crunchbase News

APRIL 5, 2024

Biotech took center stage, notching three of the top four rounds. Obsidian Therapeutics , $161M, biotech: It was another big week for biotech startups raising huge sums of cash. It also included a $50 million investment from advertising software firm AppLovin. This week, Obsidian Therapeutics leads the way.

Biotech 122

Biotech Energy Software Review Systems Review 122

TechCrunch

JULY 20, 2022

The idea of starting Healthie , a software company meant to help healthcare companies and startups handle back-office operations, came to founder Erica Jain after witnessing her parents struggle with weight loss but lack of access to a comprehensive care team. million and will use this round’s funds to continue developing their software.

Virtualization 207

Virtualization Software Review Healthcare Systems Review 207

Crunchbase News

OCTOBER 4, 2024

For perspective, we charted investment totals, color-coded by stage, for the past 11 quarters below. While the IPO market wasn’t especially active, we did see a handful of public offerings, predominantly in the biotech sector. It should be noted that Q2’s high early-stage tally was largely due to a single $6.4

Biotech 127

Biotech Technical Review Artificial Intelligence Artificial Inteligence 127

Crunchbase News

JULY 9, 2024

Automated driving company Wayve , data preparation company Scale AI and AI biotech company Xaira Therapeutics each raised billion-dollar rounds. Healthcare and biotech was the second-largest sector, raising $17 billion. Hardware companies — in large part due to AI infrastructure and semiconductor fundings — raised $11 billion.

Biotech 139

Biotech Report Software Review Technical Review 139

TechCrunch

MAY 4, 2022

Research on psychedelics was stalled for decades due to DEA scheduling, but capabilities in the fields of pharmacology and medicinal chemistry advanced significantly during this “dark age.” Cannabinoid biotech offers some glimmers of what could occur in psychedelics, with Jazz Pharma acquiring GW Pharma for $7.2

Marketing 235

Marketing Technical Review Biotech Weak Development Team 235

TechCrunch

MARCH 18, 2022

Before you can even start to disentangle someone’s genetic code, you have to start with a sample. However, as the authors of a 2020 review paper on the electrowetting industry note, the instrument was “discontinued for undisclosed reasons” in 2017. The fourth company is a biotech firm interested in synthetic biology.

Technical Review 236

Technical Review Biotech Chemicals Software Review 236

TechCrunch

MARCH 23, 2021

Meatable has a long road ahead of it, because, as Gates acknowledged in his interview with MIT Technology Review (ed. Strategic investors like DSM, one of the largest food biotech companies in Europe should help. Use code “TCARTICLE” at checkout to get 20 percent off tickets right here.

Technical Review 208

Technical Review Biotech Pharmaceuticals Software Review 208

Crunchbase News

JULY 2, 2024

Then, late last year, Cruise suspended its self-driving taxi program across the country after losing its permit to operate in San Francisco due to an incident with a pedestrian. Formation Bio , $372M, biotech: Formation Bio, an AI-enhanced pharma company, raised a $372 million Series D led by a16z. billion, per Crunchbase.

Artificial Inteligence 125

Artificial Inteligence Biotech Software Review Healthcare 125

TechCrunch

APRIL 17, 2023

These near-invisible bits of code are typically embedded in web pages to share information about users’ activity, often for analytics. Cerebral said these trackers inadvertently collected sensitive user data since it began operating in October 2019. In its disclosure to the U.S.

Software Review 243

Software Review Technical Review Insurance Healthcare 243

TechCrunch

FEBRUARY 22, 2022

The world’s labs are under pressure to do more tests and process more materials, not just due to COVID but from the growing biotech and drug development sectors — and automation is the sure path forwards. To that end Automata has been investing in the software to manage and administer its labware and robots.

Hardware 216

Hardware Biotech Technical Review Systems Review 216

DataRobot

APRIL 7, 2021

He hopes to use data from a massive biobank effort, first planned under the Obama administration and now known as All of Us, to map the genetic code of one million people. He was cofounder of a company called Arivale, which analyzed the genes of some 5,000 people, but closed in 2019 due to financial problems.

Biotech 69

Biotech Software Review Healthcare Systems Review 69

TechCrunch

APRIL 27, 2022

He puts his tally for the number of applications he’s reviewed in the “tens of thousands.” For a SaaS startup, that might mean a programmer who’s proven they can build and ship; for a biotech company, perhaps it’s less about coding and more about field expertise.

Technical Review 188

Technical Review How To Biotech Software Review 188

TechCrunch

FEBRUARY 9, 2021

Despite advances in software to help model these compounds and molecules, there are still challenges in fully understanding their shapes through a two-dimensional computer screen. San Diego-based startup Nanome uses virtual reality to solve that problem. Nanome helps scientists get on the same page quicker,” he wrote in an email.

VR 278

VR Pharmaceuticals Chemicals 3D 278

TechCrunch

DECEMBER 17, 2022

Then, this year, the Great Resignation became the Great Reset, as employers fired large percentages of their staff due to changing macroeconomic conditions. 6 investors discuss why AI is more than just a buzzword in biotech. Gift Guide: More than 20 STEM gift ideas to inspire kids to code. 7 great gifts for smart home smarties.

Technical Review 246

Technical Review Open Source Biotech ChatGPT 246

TechCrunch

FEBRUARY 9, 2022

Once samples are scanned in the lab, they could be reviewed by hematologists working from anywhere. For instance, some papers argue, the manual review of samples doesn’t often add much to doctors’ diagnostic dataset. Think of this like support software that helps a hematologist distinguish between cell types.).

Technical Review 223

Technical Review Systems Review Software Review Testing 223

Crunchbase News

JULY 12, 2024

The Silicon Valley-based firm, active in software, biotech and cleantech, participated in 26 deals last quarter. Next is Coatue, mostly due to its role as lead investor in CoreWeave ’s $1.1 billion Series C. In third place is Accel, which led Scale AI ’s $1 billion Series F.

Artificial Intelligence 130

Artificial Intelligence Artificial Inteligence Biotech Software Review 130

Crunchbase News

JUNE 18, 2024

Those with disclosed investments include a number bringing AI-enabled tools to sectors like legal tech, recruiting, code development and medical recordkeeping. San Francisco is experiencing a resurgence due to AI , which is borne out by Crunchbase data. This allows for front loading due diligence.

Software Review 127

Software Review Development Team Review Technical Review Artificial Inteligence 127

TechCrunch

AUGUST 5, 2021

The investment scene is described variously as focusing on software, clean tech, life sciences, biotech, organoids, 3D bioprinting, AI and VR/AR. We see an increase in startups coming to the city, due to livability in the lovely city and the facilities for flex working. Focus on software and clean tech. Channable, Tover.

Weak Development Team 203

Weak Development Team Technical Review Sustainability Biotech 203

Crunchbase News

SEPTEMBER 27, 2024

For software companies acquired for a billion dollars or more, private equity acquired the majority this year to date. With all the venture funding in biotech , it is no surprise that one of the largest deals was Merck ’s acquisition of New York-based eye disease therapy company Eyebiotech.

Trends 128

Trends Biotech Real Estate Artificial Intelligence 128

Crunchbase News

SEPTEMBER 3, 2024

A number of biotechs also carried out IPOs. Buyer, however, believes debut plans are getting delayed largely because many pre-IPO companies, particularly in enterprise software, are growing at slower rates than was typical during the bull market. But most weeks, the market has been uncharacteristically quiet.

Marketing 117

Marketing Technical Review Biotech Software Review 117

TechCrunch

JANUARY 11, 2021

” Bastani points out that they began the company by focusing this approach to patient education and communication on HIV, and demonstrated that using their software led to patients being 7.4 Apple and Google release sample code, UI and detailed policies for COVID-19 exposure-notification apps.

Technical Review 205

Technical Review Healthcare Software Review Windows 205

TechCrunch

MAY 28, 2021

Use discount code SCOTLANDSURVEY to save 25% off an annual or two-year Extra Crunch membership. Experiencing influx of new talent due to COVID-19. Weak in deep tech discovery, especially in biotech/therapeutics. This offer is only available to readers in the UK Europe and expires on June 30, 2021. Par Equity is leading the way.

Technical Review 235

Technical Review Artificial Inteligence Fintech Weak Development Team 235

Crunchbase News

MAY 15, 2024

It also participated in the gigantic $1 billion raise by Xaira Therapeutics , a startup at the intersection of AI and biotech. The 6-month-old startup has developed an artificial intelligence–powered coding assistant called Devin. It does not include incubators or accelerators due to the fluctuations their investment numbers can have.

Biotech 131

Biotech Artificial Intelligence Artificial Inteligence Pharmaceuticals 131

Crunchbase News

DECEMBER 6, 2024

8VC took part in the biggest deal of either firm, participating in a $42 million Series C for Sirona Medical , a San Francisco-based healthcare software developer. It does not include incubators or accelerators due to the fluctuations their investment numbers can have. -based startups. based startups.

Technical Review 117

Technical Review Biotech Chemicals Journal 117

Perficient

JANUARY 16, 2024

For more than 25 years, we’ve grown our presence, our talent, our skills, and our global footprint so that we can continually provide critical Agile software development and delivery services to the world’s biggest brands. We see great opportunity in SMEDIX and its ability to design and develop medtech software solutions.

Software Development 64

Software Development Development Team Review Software Review Technical Review 64

Crunchbase News

APRIL 9, 2025

For perspective, we charted out total investment, color-coded by stage, for the past nine quarters below. Buk , a Santiago-based HR software provider, secured $50 million in a January Series B led by Headline. Round counts declined sequentially and year over year across stages. billion valuation.

Technical Review 63

Technical Review Software Review Travel Fintech 63